Relmada Therapeutics (RLMD) Enterprise Value (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151.56% |
| Dec 31, 2025 | -569.76% |
| Sep 30, 2025 | 32.65% |
| Jun 30, 2025 | 23.80% |
| Mar 31, 2025 | 39.74% |
| Dec 31, 2024 | 17.02% |
| Sep 30, 2024 | 23.17% |
| Jun 30, 2024 | 15.76% |
| Mar 31, 2024 | 13.20% |
| Dec 31, 2023 | 9.36% |
| Sep 30, 2023 | 10.35% |
| Jun 30, 2023 | 10.50% |
| Mar 31, 2023 | 10.71% |
| Dec 31, 2022 | 19.46% |
| Sep 30, 2022 | 13.12% |
| Jun 30, 2022 | 3.94% |
| Mar 31, 2022 | -4.12% |
| Dec 31, 2021 | -140.57% |
| Sep 30, 2021 | 19.24% |
| Jun 30, 2021 | -6.20% |
| Mar 31, 2021 | 12.29% |
| Dec 31, 2020 | 4.91% |
| Sep 30, 2020 | 8.17% |
| Jun 30, 2020 | -16.68% |
| Mar 31, 2020 | 1.31% |
| Dec 31, 2019 | -1,383.38% |
| Sep 30, 2019 | 14.83% |
| Jun 30, 2019 | -348.74% |
| Mar 31, 2019 | 15.37% |
| Dec 31, 2018 | -173.44% |
| Sep 30, 2018 | 60.36% |
| Jun 30, 2018 | 47.41% |
| Mar 31, 2018 | 28.32% |
| Dec 31, 2017 | -26.79% |
| Sep 30, 2017 | -173.87% |
| Jun 30, 2017 | 37.95% |
| Mar 31, 2017 | 41.53% |
| Dec 31, 2016 | 24.23% |
| Sep 30, 2016 | 26.81% |
| Jun 30, 2016 | 25.10% |
| Mar 31, 2016 | 24.98% |
| Dec 31, 2015 | 21.07% |
| Sep 30, 2015 | 14.71% |
| Jun 30, 2015 | 16.64% |
| Mar 31, 2015 | 14.20% |
| Dec 31, 2014 | -14.71% |
| Sep 30, 2014 | -7.14% |
| Jun 30, 2014 | -939.57% |
| Nov 30, 2013 | 59.67% |
| Feb 28, 2013 | 28.16% |
| Nov 30, 2012 | -16.73% |